Capricor Therapeutics Insiders Sold Shares Worth Over $1.5M

Krasney Karen, an officer serving as EVP, General Counsel, sold 24,100 shares of common stock under a Rule 10b5-1 trading plan at a weighted average price of $30.38 per share, with individual sale prices ranging from $30.00 to $30.88, for total proceeds of $732,158, and after the sale she directly owns 30,547 shares of common stock.

Anthony Bergmann, an officer serving as Chief Financial Officer, sold 24,100 shares of common stock under a 10b5-1 trading plan adopted in December 2025 at a weighted average price of $30.38 per share, with individual sale prices ranging from $30.00 to $30.88, for total proceeds of $732,158 disposed of on June 25, 2026, and after the transaction he directly owns 11,223 shares of common stock; shares referenced in the filing vested 1/48th on the first day of each month commencing February 1, 2022.

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.